• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质的药物递送系统的酶学特性

Enzymatic characterization of lipid-based drug delivery systems.

作者信息

Ljusberg-Wahren Helena, Seier Nielsen Flemming, Brogård Mattias, Troedsson Emma, Müllertz Anette

机构信息

Camurus AB, Ideon, Gamma 2, Sölvegatan 41, SE-223 70 Lund, Sweden.

出版信息

Int J Pharm. 2005 Jul 25;298(2):328-32. doi: 10.1016/j.ijpharm.2005.02.038.

DOI:10.1016/j.ijpharm.2005.02.038
PMID:15979260
Abstract

The present work introduces a simple and robust in vitro method for enzymatic characterisation of surface properties of lipid dispersions in aqueous media. The initial lipolysis rate in biorelevant media, using pancreatic lipase and a self-microemulsifying formulation (SMEDDS) containing digestible lipids as substrate, was determined. The impact of incorporating two sparingly water soluble model drugs, probucol and halofantrine, into the SMEDDS was studied. It was found that both model drugs reduced the initial rate of lipolysis compared with the vehicle, probucol having a larger effect than halofantrine. The reduction of initial lipolysis rate indicates that probucol and halofantrine are bound in the water/emulsion interface limiting the substrate availability.

摘要

本研究介绍了一种简单且可靠的体外方法,用于酶促表征水性介质中脂质分散体的表面性质。测定了在生物相关介质中,以胰脂肪酶和含有可消化脂质的自微乳化制剂(SMEDDS)为底物时的初始脂解速率。研究了将两种水溶性较差的模型药物普罗布考和卤泛群加入SMEDDS中的影响。结果发现,与载体相比,两种模型药物均降低了初始脂解速率,普罗布考的作用比卤泛群更大。初始脂解速率的降低表明,普罗布考和卤泛群结合在水/乳液界面,限制了底物的可及性。

相似文献

1
Enzymatic characterization of lipid-based drug delivery systems.基于脂质的药物递送系统的酶学特性
Int J Pharm. 2005 Jul 25;298(2):328-32. doi: 10.1016/j.ijpharm.2005.02.038.
2
In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.结合动态脂解模型和神经模糊网络的自乳化药物递送系统的体外-体内相关性
Eur J Pharm Biopharm. 2008 Aug;69(3):887-98. doi: 10.1016/j.ejpb.2008.01.022. Epub 2008 Feb 1.
3
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).新型超饱和自微乳给药系统(super-SNEDDS)的体外和体内性能。
J Control Release. 2012 May 30;160(1):25-32. doi: 10.1016/j.jconrel.2012.02.027. Epub 2012 Mar 3.
4
Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.司骨化醇II的生物利用度:含中链和长链甘油三酯的口服自微乳化药物递送系统(SMEDDS)的开发与特性研究
Eur J Pharm Sci. 2006 Jun;28(3):233-42. doi: 10.1016/j.ejps.2006.02.005. Epub 2006 May 2.
5
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.通过体外动态脂解模型优化口服脂质体药物递送系统的选择,以提高难溶性药物的口服生物利用度。
J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1.
6
Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of alpha-tocopherol self-emulsified drug delivery systems (SEDDS).脂解作用与药典规定的溶出度作为α-生育酚自乳化药物递送系统(SEDDS)体外特性表征替代技术的比较。
Int J Pharm. 2008 Mar 20;352(1-2):104-14. doi: 10.1016/j.ijpharm.2007.10.023. Epub 2007 Oct 26.
7
Morphological observations on a lipid-based drug delivery system during in vitro digestion.基于脂质的药物递送系统在体外消化过程中的形态学观察
Eur J Pharm Sci. 2007 Jun;31(2):85-94. doi: 10.1016/j.ejps.2007.02.009. Epub 2007 Feb 23.
8
Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.基于脂质和表面活性剂的普罗布考制剂在小型猪体内的生物利用度:液滴大小和饮食状态的影响。
Eur J Pharm Biopharm. 2008 Jun;69(2):553-62. doi: 10.1016/j.ejpb.2007.12.020. Epub 2008 Jan 3.
9
Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.含有长春西汀的自微乳化药物递送系统的制备与评价
Drug Dev Ind Pharm. 2009 May;35(5):603-11. doi: 10.1080/03639040802488089.
10
Impact of interfacial composition on emulsion digestion and rate of lipid hydrolysis using different in vitro digestion models.不同体外消化模型中界面组成对乳液消化和脂肪水解速率的影响。
Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):321-30. doi: 10.1016/j.colsurfb.2010.12.001. Epub 2010 Dec 7.

引用本文的文献

1
Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.探索脂质提高亲脂性候选药物生物利用度的潜力:综述
Saudi Pharm J. 2023 Dec;31(12):101870. doi: 10.1016/j.jsps.2023.101870. Epub 2023 Nov 10.
2
Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.用于制备脂质基固体口服制剂的无溶剂熔融技术。
Pharm Res. 2015 May;32(5):1519-45. doi: 10.1007/s11095-015-1661-y. Epub 2015 Mar 19.
3
Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.
脂解作用对不同核/壳药物位置的自微乳化药物递送系统(SMEDDS)药物释放的影响。
AAPS PharmSciTech. 2014 Jun;15(3):731-40. doi: 10.1208/s12249-014-0096-9. Epub 2014 Feb 20.
4
In vitro digestion of the self-emulsifying lipid excipient Labrasol(®) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate.自乳化脂质辅料 Labrasol(®)在胃肠脂肪酶中的体外消化及其胶体结构对脂肪酶解速率的影响。
Pharm Res. 2013 Dec;30(12):3077-87. doi: 10.1007/s11095-013-1053-0. Epub 2013 May 2.
5
Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.设计用于口服给药的脂基制剂:对消化的影响
AAPS PharmSciTech. 2012 Jun;13(2):637-46. doi: 10.1208/s12249-012-9787-2. Epub 2012 May 1.
6
Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.在达那唑的自乳化脂质基制剂中,相对于脂质增加表面活性剂(聚氧乙烯蓖麻油)的比例会降低比格犬的口服生物利用度。
Pharm Res. 2007 Apr;24(4):748-57. doi: 10.1007/s11095-006-9194-z. Epub 2007 Feb 15.
7
Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.使用动态体外脂肪分解模型来合理设计难溶性药物的口服制剂:与体内数据的相关性以及与大鼠肠细胞内过程的关系。
Pharm Res. 2006 Sep;23(9):2165-74. doi: 10.1007/s11095-006-9054-x. Epub 2006 Aug 11.